You Don’t Have to Face Depression Alone. Hope and Healing Start Here.
Major Depressive Disorder (MDD) is treatable, and other options exist when first treatments haven’t helped enough. Learn about approaches such as TMS and Spravato® (esketamine), and find clinics that list them in MDDCare’s directory.
- 5,600+ Listed Providers
- FDA-Cleared & Approved Options
- Insurance Information by Clinic
Evidence-Based Advanced Interventions
When first-line antidepressants have not brought enough relief, other options such as TMS and esketamine may be considered with a qualified healthcare professional.
Neuromodulation Protocol
Transcranial Magnetic Stimulation (TMS)
TMS uses focused magnetic pulses, similar in strength to those used in MRI, to stimulate an area of the brain involved in mood regulation. Because it is non-invasive and does not circulate through the bloodstream, it avoids the systemic side effects associated with many medications. Common side effects include scalp discomfort and headache.
- Targeted magnetic stimulation of the prefrontal cortex.
- No anesthesia or sedation; most people can drive themselves after a session.
- Studied in adults with MDD who did not improve enough with antidepressants; response varies.
Supervised Nasal Spray
Spravato® (Esketamine Nasal Spray)
SPRAVATO® is a prescription esketamine nasal spray for adults with treatment-resistant depression. Unlike traditional antidepressants that mainly act on monoamines, esketamine affects glutamate signaling. It is self-administered under direct supervision in a healthcare setting, followed by at least two hours of monitoring.
- Some studies measured symptom changes within the first day; response varies.
- Administered under direct healthcare-provider supervision through the SPRAVATO® REMS.
- Coverage varies by plan; confirm with your insurer and the clinic.
Understanding the Depression Spectrum
Depression is not one uniform condition. Understanding the differences can help you have more informed conversations with a healthcare professional.
Major Depressive Disorder (MDD)
Characterized by a persistent low mood, pervasive loss of interest, sleep disruption, and profound fatigue persisting beyond two weeks. Significantly impairs cognitive clarity, professional life, and interpersonal relationships.
SSRIs/SNRIs, targeted Cognitive Behavioral Therapy (CBT), and lifestyle stabilization.
Treatment-Resistant Depression (TRD)
Clinically defined when an individual has not achieved sufficient remission after two or more distinct medication courses of adequate dose and duration. TRD does not mean “untreatable”—other treatment approaches may be considered.
Repetitive TMS, Spravato® (esketamine), and specialized psychiatric care.
Recurrent & Persistent Depressive States
Episodes that cycle over multiple years (dysthymia or double depression). Often associated with functional exhaustion, chronic inflammation, or neuroplastic wear requiring maintenance regimens and enduring therapeutic alliance.
Maintenance treatment plans, psychotherapy, and ongoing medication management.
Explore our curated selection of articles on Depression care
Educational guides on depression, treatment options, and daily life.

How to beat Depression with TMS or Esketamine
Struggling with depression and looking for better treatment options? If traditional antidepressants haven’t worked, advanced therapies like TMS and Spravato (Esketamine) could…Read article
Is Your Teen Depressed? Recognizing the Early Signs of MDD
Teenagers go through mood swings, but when does sadness turn into something more serious? Major Depressive Disorder (MDD) in teens can be…Read article
How depression affects motivation & what you can do about it
Ever feel like even the smallest tasks feel overwhelming? You’re not alone. Depression doesn’t just affect mood—it also impacts motivation, energy, and…Read article
Depression Isn’t Just Mental: How MDD Impacts Your Body
Depression isn’t just in your head—it affects your whole body. While Major Depressive Disorder (MDD) is known for its emotional toll, it…Read article
Cutting-Edge Treatments for MDD: What’s Changing in Depression Care
Depression treatment is advancing beyond traditional medications. If you’ve struggled with antidepressants or are looking for more effective options, you’ll be glad…Read article
Sad or Depressed? How to Tell the Difference
Everyone feels sad sometimes, but when does it become something more serious? Sadness is a normal human emotion, while depression is a…Read article
Can Poor Sleep Cause Depression and Anxiety? Here’s the Connection
Tossing and turning at night? It’s not just frustrating—it could be affecting your mental health. Studies show that poor sleep can lead…Read articleFrequently Asked Questions
Educational answers about depression and treatment options. Discuss your situation with a qualified healthcare professional.
What is Major Depressive Disorder (MDD), and what causes it?
Major Depressive Disorder is a complex biological and psychological mood disorder, not a personal failing or temporary sorrow. It arises from an interplay of neurocircuitry dysregulation, genetic predispositions, chronic hormonal and inflammatory stressors, and altered neuroplasticity in mood-regulating areas such as the hippocampus and prefrontal cortex.
Does insurance cover TMS and Spravato® treatments?
Many insurance plans, including Medicare, may cover TMS and Spravato® for treatment-resistant depression when plan criteria are met, often with prior authorization. Coverage varies by plan, clinical indication, and treatment setting. Confirm benefits and requirements directly with your insurer and the clinic. MDDCare does not determine coverage.
How does Spravato® (esketamine) work?
Traditional antidepressants mainly act on monoamines such as serotonin and can take several weeks to reach full effect. Esketamine is an NMDA receptor antagonist that affects glutamate signaling. Some clinical studies measured symptom changes within the first day, but the exact mechanism is not fully understood and response varies.
How long do treatment courses typically last?
An acute TMS course typically involves sessions five days a week for about 6 weeks, sometimes followed by a taper; session length depends on the device and protocol. For treatment-resistant depression, Spravato® is given twice weekly in weeks 1–4, once weekly in weeks 5–8, then once weekly or every two weeks based on response.
How does TMS differ from standard medication?
Antidepressants circulate through the body via the bloodstream, which can cause side effects such as nausea, weight gain, fatigue, or sexual dysfunction. TMS delivers focused magnetic pulses to a specific brain region and does not circulate through the body. It can cause scalp discomfort or headache, and seizures are a rare risk.
Can MDD be prevented or permanently cured?
Clinicians generally avoid the word “cure,” but many people with MDD reach remission and stay well with ongoing care. Treatment plans may combine medication, psychotherapy, and options such as TMS or Spravato®, along with relapse-prevention strategies discussed with a healthcare professional.